August 11, 2016
A New Jersey federal judge on Thursday dismissed Exeltis USA Dermatology Inc.’s trade secrets infringement and unfair competition suit against Acella Pharmaceuticals LLC, concluding that Exeltis failed to explain which proprietary information was taken regarding its skin disorder treatments Salvax and Hydro 35.
October 14, 2015
Exeltis USA Dermatology Inc. on Tuesday brought a trade secret infringement and unfair competition lawsuit against Acella Pharmaceuticals LLC in New Jersey federal court, claiming its competitor improperly acquired, disclosed and used proprietary information for its Salvax and Hydro 35 products.